Skip to content

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

OPK Opko Health Inc.
$1.62 0.62% +0.01
Notify me if price changes either direction
Interactive Brokers Logotype

Buy OPK stocks now with Interactive Brokers – the most advanced investment platform

Contents
  • Performance
  • Key stats
  • Financials
  • US politician trades

Opko Health Inc. (OPK)

Loading

Key Stats

Market cap. 1.2B
Enterprise value 1.3B
Trailing PE -5.4166666666667
Forward PE -4.689366
PEG Ratio 0.057175925925926
Enterprise to EBITDA -16.616
Enterprise to revenue 2.209
Price to book MRQ 1.0144928
Price to sales TTM 2.0438757

Financials

Fiscal Year Ends 2025-12-31
Most Recent Quarter (MRQ) 2026-06-30
Revenue (TTM) 587.9M
EBITDA -78172000
Diluted EPS TTM -0.09
Total Cash (MRQ) 300.8M
Current ratio (MRQ) 3.349
Operating Cash Flow (TTM) -123378000

OPK trades by the US politicians

Percentage
0% 0 sells
100% 0 buys
Amount
$0 0 sells
$0 0 buys
In the last 0 months

Recent OPK News

Home

IMPORTANT NOTICE

Finbold is a news and information website. This Site may contain sponsored content, advertisements, and third-party materials, for which Finbold expressly disclaims any liability.

RISK WARNING: Cryptocurrencies are high-risk investments and you should not expect to be protected if something goes wrong. Don’t invest unless you’re prepared to lose all the money you invest. (Click here to learn more about cryptocurrency risks.)

By accessing this Site, you acknowledge that you understand these risks and that Finbold bears no responsibility for any losses, damages, or consequences resulting from your use of the Site or reliance on its content. Click here to learn more.